{"schema_version":"secwatch.filing_event.v1","accession":"0001641172-25-014877","form_type":"8-K","ticker":"ERNA","cik":"0000748592","company_name":"Ernexa Therapeutics Inc.","filed_at":"2025-06-12T23:59:59+00:00","discovered_at":"2026-05-14T18:02:51.149367+00:00","generated_at":"2026-05-19T11:48:10.098747+00:00","sec_items":["5.03","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Ernexa Therapeutics effects 1-for-15 reverse stock split effective June 12, 2025","bullets":["Certificate of amendment filed with Delaware Secretary of State on June 10, 2025.","Reverse stock split ratio is 1-for-15.","Effective date of reverse stock split is June 12, 2025."],"urls":{"canonical":"https://secwatch.observer/filing/0001641172-25-014877","json":"https://secwatch.observer/filing/0001641172-25-014877.json","markdown":"https://secwatch.observer/filing/0001641172-25-014877.md","text":"https://secwatch.observer/filing/0001641172-25-014877.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/748592/000164117225014877/0001641172-25-014877-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/748592/000164117225014877/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-19T11:48:10.098747+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"d6384536bdd4862778d392798a350da155f554d9","claim":"Ernexa Therapeutics Inc.: Reverse stock split of common stock at 1-for-15 ratio via certificate of amendment to Restated Certificate of Incorporation (effective 2025-06-12).","evidence_excerpt":"Effective June 12, 2025, Ernexa Therapeutics Inc. (the “Company”), filed a certificate of amendment to the Company’s Restated Certificate of Incorporation, as amended (the “Amended COI”) with the Secretary of State of Delaware to effect a reverse stock split of the Company’s common stock, at a ratio of 1-for-15.","evidence_source":"SEC 8-K Item 5.03/5.05/5.06","evidence_url":"https://www.sec.gov/Archives/edgar/data/748592/000164117225014877/0001641172-25-014877-index.htm","confidence":0.9,"family_label":"Governance Changes","details":[{"label":"Change","value":"charter amendment"},{"label":"Effective","value":"2025-06-12"}],"fact_type":"governance_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}